MULROY DENNIS (Chief Financial Officer) received a stock award from LA JOLLA PHARMACEUTICAL CO
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/19/2020ACC: 0000920465-20-000076
Officer· Chief Financial Officer
Since Oct 2018
+112.00
Net shares
Net buyer
$328.16
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
112.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+56.00
Price / share
$5.86
Trade value
$328.16
% of position
1.1%
5/15/2020
4.93K→4.99K
Total
Net shares
+56.00
Net value
$328.16
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2020 | A · Award | +56.00 | $5.86 | $328.16 | 1.1% | 4.93K | 4.99K |
| Total | +56.00 | $328.16 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
56.00 shares
Shares
+56.00
Strike price
6.89
Held after
56.00
Exercisable
—
5/15/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock56.00 shares | 5/15/2020 | A · Award | +56.00 | 6.89 | — | 56.00 |